UnknownPhase 2NCT00787826
Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine
Studying Tularemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- U.S. Army Medical Research and Development Command
- Principal Investigator
- Anthony Cardile, DOUSAMRIID Medical Division
- Intervention
- Live Francisella Tularensis Vaccine(biological)
- Enrollment
- 1000 target
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2009 – 2021
Study locations (1)
- U.S. Army Medical Research Institute of Infectious Diseases, Fort Deterick, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00787826 on ClinicalTrials.gov